Table of Content



1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Wearable Injectors Market – By Type
1.3.2 North America Wearable Injectors Market – By Application
1.3.3 North America Wearable Injectors Market – By Country

2. North America Wearable Injectors Market – Key Takeaways

3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. North America Wearable Injectors Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Wearable Injectors Market - North America PEST Analysis
4.3 Expert Opinion

5. North America Wearable Injectors Market - Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Increasing Chronic Diseases Prevalence
5.1.2 Technological Advancements and Design Development
5.1.3s Conventional Drug Delivery System Limitations
5.2 Key Market Restraints
5.2.1 Lack of Adoption in Emerging Countries
5.3 Market Opportunities
5.3.1 Increasing Demand for Biologics
5.4 Future Trends
5.4.1 Integration of Wearable Injectors During Early Drug Development
5.5 Impact analysis

6. Wearable Injectors Market – North America Analysis
6.1 North America Wearable Injectors Market Revenue Forecasts and Analysis

7. North America Wearable Injectors Market Analysis And Forecasts To 2027 – By Type
7.1 Overview
7.2 North America Wearable Injectors market, By Type 20110 & 2027 (%)
7.2.1 North America Wearable Injectors Market Revenue and Forecasts to 2027, By Type (US$ Mn)
7.3 On-Body Injectors
7.3.1 Overview
7.3.2 North America On-Body Injectors Market Revenue and Forecast to 2027 (US$ Mn)
7.4 Off-Body Injectors
7.4.1 Overview
7.4.2 North America Off-Body Injectors Market Revenue and Forecasts to 2027 (US$ Mn)

8. North America Wearable Injectors Market Analysis – By Application
8.1 Overview
8.2 North America Wearable Injectors Market, By Application 20110-2027 (%)
8.2.1 North America Wearable Injectors Market Revenue and Forecasts to 2027, By Application (US$ Mn)
8.3 Diabetes
8.3.1 Overview
8.3.2 North America Diabetes Market Revenue and Forecasts to 2027 (US$ Mn)
8.4 Oncology
8.4.1 Overview
8.4.2 North America Oncology Market Revenue and Forecasts to 2027 (US$ Mn)
8.5 Cardiovascular Disease
8.5.1 Overview
8.5.2 North America Cardiovascular Disease Market Revenue and Forecasts to 2027 (US$ Mn)
8.6 Autoimmune Disease
8.6.1 Overview
8.6.2 North America Autoimmune Disease Market Revenue and Forecasts to 2027 (US$ Mn)
8.7 Other Applications
8.7.1 Overview
8.7.2 North America Other Applications Market Revenue and Forecasts to 2027 (US$ Mn)

9. North America Wearable Injectors Market Analysis – By End User
9.1 Overview
9.2 North America Wearable Injectors Market, By End User 2019-2027 (%)
9.2.1 North America Wearable Injectors Market Revenue and Forecasts to 2027, By End User (US$ Mn)
9.3 Hospitals and Clinics
9.3.1 Overview
9.3.2 North America Hospitals and Clinics Market Revenue and Forecasts to 2027 (US$ Mn)
9.4 Homecare Setting
9.4.1 Overview
9.4.2 North America Homecare Setting Market Revenue and Forecasts to 2027 (US$ Mn)
9.5 Other End User
9.5.1 Overview
9.5.2 North America Other End User Market Revenue and Forecasts to 2027 (US$ Mn)


10. Wearable Injectors Market Revenue and Forecasts To 2027 – Geographical Analysis
10.1 North America Wearable Injectors Market Revenue and Forecasts To 2027
10.1.1 Overview
10.1.2 North America: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)
10.1.3 North America: Wearable Injectors Market, by Type, 2018–2027 (USD Million)
10.1.4 North America: Wearable Injectors Market, by Application, 2018–2027 (USD Million)
10.1.4 North America: Wearable Injectors Market, by End User, 2018–2027 (USD Million)
10.1.5 North America: Wearable Injectors Market, by Country, 20110 & 2027 (%)
10.1.6 US: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)
10.1.6.1 US: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)
10.1.6.2 US: Wearable Injectors Market, by Type, 2018–2027 (USD Million)
10.1.6.3 US: Wearable Injectors Market, by Application, 2018–2027 (USD Million)
10.1.6.3 US: Wearable Injectors Market, by End User, 2018–2027 (USD Million)
10.1.7 Canada: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.1 Canada: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.2 Canada: Wearable Injectors Market, by Type, 2018–2027 (USD Million)
10.1.7.3 Canada: Wearable Injectors Market, by Application, 2018–2027 (USD Million)
10.1.7.3 Canada: Wearable Injectors Market, by End User, 2018–2027 (USD Million)

10.1.8 Mexico: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.1 Mexico: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.2 Mexico: Wearable Injectors Market, by Type, 2018–2027 (USD Million)
10.1.8.3 Mexico: Wearable Injectors Market, by Application, 2018–2027 (USD Million)
10.1.8.3 Mexico: Wearable Injectors Market, by End User, 2018–2027 (USD Million)

11. Impact of COVID-19 Pandemic on North America Wearable Injectors Market
11.1 North America: Impact Assessment of COVID-19 Pandemic

12. Wearable Injectors Market –Industry Landscape
12.1 Overview
12.2 Growth Strategies Done by the Companies in the Market, (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview

13. Company Profiles
13.1 BD
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 CeQur SA
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Debiotech S.A.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 E3D Elcam Drug Delivery Devices
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Insulet Corporation
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Gerresheimer AG
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Tandem Diabetes Care Inc.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Zealand Pharma A/S
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 West Pharmaceutical Services, Inc.
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Ypsomed AG
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
13.11 Medtronic
13.11.1 Key Facts
13.11.2 Business Description
13.11.3 Products and Services
13.11.4 Financial Overview
13.11.5 SWOT Analysis
13.11.6 Key Developments
13.13 Amgen, Inc.
13.13.1 Key Facts
13.13.2 Business Description
13.13.3 Products and Services
13.13.4 Financial Overview
13.13.5 SWOT Analysis
13.13.6 Key Developments
14. Appendix
14.1 About the Insight Partners
14.2 Word Index



List of Figures


Figure 1. Wearable Injectors Market Segmentation
Figure 2. Wearable Injectors Segmentation, By Region
Figure 4. On-body Injectors Segment Held Largest Share of Wearable Injectors Market
Figure 6. Wearable Injectors Market, by Geography (US$ Million)
Figure 7. Global Wearable Injectors Market – Leading Country Markets (US$ Million)
Figure 8. Global Wearable Injectors Market, Industry Landscape
Figure 9. North America : PEST Analysis
Figure 10. Europe: PEST Analysis
Figure 11. Asia Pacific PEST Analysis
Figure 12. Middle East & Africa PEST Analysis
Figure 13. South & Central America PEST Analysis
Figure 14. Wearable Injectors Market Impact Analysis of Driver and Restraints
Figure 15. Global Wearable Injectors Market – Revenue Forecast and Analysis – 2019- 2027
Figure 16. Global Wearable Injectors Market – By Geography Forecast and Analysis – 2019- 2027
Figure 17. Market Positioning Of Key Players In Global Wearable Injectors Market
Figure 18. Wearable Injectors Market Share, by Type, 2019 and 2027 (%)
Figure 19. On-body injectors: Wearable Injectors Market Market– Revenue and Forecast to 2027 (USD Million)
Figure 20. Off-body injectors: Wearable Injectors Market Market– Revenue and Forecast to 2027 (USD Million)
Figure 21. Wearable Injectors Market Share, by Application, 2019 and 2027 (%)
Figure 22. Oncology: Wearable Injectors Market Market– Revenue and Forecast to 2027 (USD Million)
Figure 23. Diabetes: Wearable Injectors Market Market– Revenue and Forecast to 2027 (USD Million)
Figure 24. Autoimmune Disease: Wearable Injectors Market Market– Revenue and Forecast to 2027 (USD Million)
Figure 25. Cardiovascular Disease: Wearable Injectors Market Market– Revenue and Forecast to 2027 (USD Million)
Figure 26. Other Applications: Wearable Injectors Market Market– Revenue and Forecast to 2027 (USD Million)
Figure 27. Wearable Injectors Market Share, by End user, 2019 and 2027 (%)
Figure 28. Homecare Setting: Wearable Injectors Market Market– Revenue and Forecast to 2027 (USD Million)
Figure 29. Hospitals and Clinics: Wearable Injectors Market Market– Revenue and Forecast to 2027 (USD Million)
Figure 30. Other End Users: Wearable Injectors Market Market– Revenue and Forecast to 2027 (USD Million)
Figure 31. North America: Wearable Injectors Market, by Key Country – Revenue (2019) (USD Million)
Figure 32. North America Wearable Injectors Market Revenue and Forecast to 2027 (USD Million)
Figure 33. North America: Wearable Injectors Market, by Country, 2019 & 2027 (%)
Figure 34. US: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)
Figure 35. Canada: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)
Figure 36. Canada Wearable Injectors Market, by Type – Revenue and Forecast to 2027 (USD Million)
Figure 37. Mexico: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)
Figure 31. Impact of Covid-19 Pandemic In North American Country Markets

 

List of Tables


Table 1. North America Wearable Injectors Market Revenue and Forecasts To 2027, By Type (US$ Mn)
Table 2. North America Wearable Injectors Market Revenue and Forecasts To 2027, By Application (US$ Mn)
Table 3. North America Wearable Injectors Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 4. North America Wearable Injectors Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 1. North America Wearable Injectors Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 2. US Wearable Injectors Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 3. US Wearable Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)
Table 4. US Wearable Injectors Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 5. Canada Wearable Injectors Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 6. Canada Wearable Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)
Table 7. Canada Wearable Injectors Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 8. Mexico Wearable Injectors Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 9. Mexico Wearable Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)
Table 10. Mexico Wearable Injectors Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 11. List of Abbreviation